Literature DB >> 7107769

High-performance liquid chromatographic analysis of the metabolism of primaquine and the identification of a new mammalian metabolite.

J K Baker, J D McChesney, C D Hufford, A M Clark.   

Abstract

Using rats that had been dosed with 20 mg/kg of primaquine diphosphate (11.4 mg/kg free base), it was found that the drug underwent a metabolic oxidative deamination to give 8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline. The presence of this new mammalian metabolite was verified using high-performance liquid chromatographic, gas chromatographic, and mass spectral methods. A quantitative high-performance liquid chromatographic method for the determination of primaquine and the carboxylic acid metabolite in plasma using only 50 microliters of whole blood from the rat was developed and the method could be used to detect levels as low as 0.05 microgram/ml of the metabolite. Following intravenous administration of the drug, it was found that the plasma levels of primaquine fell very rapidly and after 30 min, the levels of the metabolite were much higher than those of primaquine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107769     DOI: 10.1016/s0378-4347(00)81431-0

Source DB:  PubMed          Journal:  J Chromatogr


  16 in total

1.  Selective toxicity of the antimalarial primaquine-evidence for both uncoupling and inhibitory effects of a metabolite on the energetics of mitochondria and its ATP synthase complex.

Authors:  J K Baker; J M Hullihen; P L Pedersen
Journal:  Pharm Res       Date:  1986-10       Impact factor: 4.200

2.  A simple colorimetric method for the determination of primaquine metabolites in urine.

Authors:  J K Baker; J D McChesney; L Jorge
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

3.  Increased bioavailability of primaquine using poly(ethylene oxide) matrix extended-release tablets administered to beagle dogs.

Authors:  C D Bertol; P R Oliveira; G Kuminek; G S Rauber; H K Stulzer; M A S Silva
Journal:  Ann Trop Med Parasitol       Date:  2011-10

Review 4.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

5.  Novel sulfur-containing microbial metabolite of primaquine.

Authors:  C D Hufford; J K Baker; J D McChesney; A M Clark
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

6.  Production of a novel dimeric metabolite of primaquine by Streptomyces rimosus.

Authors:  A M Clark; C D Hufford; R K Puri; J D McChesney
Journal:  Appl Environ Microbiol       Date:  1984-03       Impact factor: 4.792

7.  Microbial transformation of primaquine by Candida tropicalis.

Authors:  A M Clark; C D Hufford; R C Gupta; R K Puri; J D McChesney
Journal:  Appl Environ Microbiol       Date:  1984-03       Impact factor: 4.792

8.  The pharmacokinetics of primaquine in calves after subcutaneous and intravenous administration.

Authors:  H Yoshimura; Y S Endoh; Y Ishihara; S Nakamura; Y Inoue
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

9.  Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite.

Authors:  G W Mihaly; S A Ward; G Edwards; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

10.  Effect of aliphatic side-chain substituents on the antimalarial activity and on the metabolism of primaquine studied using mitochondria and microsome preparations.

Authors:  J K Baker; R H Yarber; N P Nanayakkara; J D McChesney; F Homo; I Landau
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.